We will help you to make the right decision when buying or selling company shares or products and investments in companies.

Due Diligence / Situation Audit

If you are looking to buy or sell a product or business, or take an equity share in a company, we can support you from the outset with a situation audit. The success of your project is dependent on knowing the value of a product or a company, and more specifically its future potential. Through in-depth due diligence, we will map out the decision-making process and help you to assess the risks. We review and assess all the data related to research, development and production. We evaluate the patent situation and the target market, both from the supplier and consumer side, as well as the risks for future development.

Due Diligence

If you are looking to buy a product or take an equity interest in a company, we will help you assess the value of the product or the business through a due diligence process. A thorough audit is fundamental to your decision-making process for acquisition and financing. That is why we provide you with a detailed analysis of the strengths, weaknesses, potential risks and future opportunities for success.

  • reviewing the research data
  • evaluating the patent situation
  • analysing the risks
  • valuing the product or company

We will explore all the relevant data related to research, preclinical and clinical development and production to the depth and extent required. We will evaluate the patent situation and the target market, both on the supplier and consumer side. Where necessary, the patent search can be supplemented by a Freedom to Operate (FTO) analysis.

For projects within the development phase or those recently completed, our team will check the feasibility and transferability of laboratory developed processes together with scalability for future commercial production. This is to ensure that a product that functions on a small scale is capable of succeeding at a larger commercial level.

Through our industry experience, we are able to make an insightful and astute assessment of development costs and the cost of goods sold (COGS) and thus determine whether a drug or medical device has an attractive commercial potential in the marketplace. We estimate the prospects of success in the clinical development process (preclinical and clinical) and determine the chances of a drug candidate being successful in clinical trials.

We review the market prospects for a product or service (or the likelihood of acceptance in the national register of medical products), as well as the regulatory approval and remuneration process for a drug by a country’s health insurance providers.

We also ensure compliance with all regulatory affairs and quality criteria and analyse the risks of potential future political developments in the health sector.

Using all the collected data, we work with you to jointly determine the current value of the product or company, and its future value depending on specific steps in development thus building the foundations for making active decisions.

Due Diligence

If you are looking to buy a product or take an equity interest in a company, we will help you assess the value of the product or the business through a due diligence process. A thorough audit is fundamental to your decision-making process for acquisition and financing. That is why we provide you with a detailed analysis of the strengths, weaknesses, potential risks and future opportunities for success.

We will explore all the relevant data related to research, preclinical and clinical development and production to the depth and extent required. We will evaluate the patent situation and the target market, both on the supplier and consumer side. Where necessary, the patent search can be supplemented by a Freedom to Operate (FTO) analysis.

For projects within the development phase or those recently completed, our team will check the feasibility and transferability of laboratory developed processes together with scalability for future commercial production. This is to ensure that a product that functions on a small scale is capable of succeeding at a larger commercial level.

Through our industry experience, we are able to make an insightful and astute assessment of development costs and the cost of goods sold (COGS) and thus determine whether a drug or medical device has an attractive commercial potential in the marketplace. We estimate the prospects of success in the clinical development process (preclinical and clinical) and determine the chances of a drug candidate being successful in clinical trials.

We review the market prospects for a product or service (or the likelihood of acceptance in the national register of medical products), as well as the regulatory approval and remuneration process for a drug by a country’s health insurance providers.

We also ensure compliance with all regulatory affairs and quality criteria and analyse the risks of potential future political developments in the health sector.

Using all the collected data, we work with you to jointly determine the current value of the product or company, and its future value depending on specific steps in development thus building the foundations for making active decisions.

  • reviewing the research data
  • evaluating the patent situation
  • analysing the risks
  • valuing the product or company

Situation Audit

If you are preparing for a new round of investment or potential divestiture, then having the best possible objective value of a product, service or start-up is fundamental to securing a successful deal. On those occasions when a life science company needs a fresh injection of cash, then a situation audit can help it to assess the extent of its bargaining power.

  • patent check
  • feasibility check
  • cost assessment
  • prospects of successt
  • data room

Similarly, investors use due diligence to make sure they are not backing the wrong horse. We will assess the key factors that contribute to the success of a product or service. This assessment is based on our own technical expertise, the experience of our team and our extensive sector contacts.

We conduct a patent search and review patents for their usability (using Freedom to Operate analysis where appropriate).

Through our industry experience, we are able to make an insightful and astute assessment of development and manufacturing costs thus determining whether a drug or medical device has commercial potential in the marketplace. We estimate the prospects of success in the clinical development process (preclinical and clinical) and determine the chances of a drug candidate being successful in clinical trials. We review the market prospects for a product or service (or the likelihood of acceptance in the national register of medical products) as well as the regulatory approval and remuneration process for a drug by health insurance providers.

We ensure compliance with all regulatory requirements and quality criteria. Where required, we are able to produce comprehensive documentation for due diligence in our own data room.

Situation Audit

If you are preparing for a new round of investment or potential divestiture, then having the best possible objective value of a product, service or start-up is fundamental to securing a successful deal. On those occasions when a life science company needs a fresh injection of cash, then a situation audit can help it to assess the extent of its bargaining power.

Similarly, investors use due diligence to make sure they are not backing the wrong horse. We will assess the key factors that contribute to the success of a product or service. This assessment is based on our own technical expertise, the experience of our team and our extensive sector contacts.

We conduct a patent search and review patents for their usability (using Freedom to Operate analysis where appropriate).

Through our industry experience, we are able to make an insightful and astute assessment of development and manufacturing costs thus determining whether a drug or medical device has commercial potential in the marketplace. We estimate the prospects of success in the clinical development process (preclinical and clinical) and determine the chances of a drug candidate being successful in clinical trials. We review the market prospects for a product or service (or the likelihood of acceptance in the national register of medical products) as well as the regulatory approval and remuneration process for a drug by health insurance providers.

We ensure compliance with all regulatory requirements and quality criteria. Where required, we are able to produce comprehensive documentation for due diligence in our own data room.

  • patent check
  • feasibility check
  • cost assessment
  • prospects of successt
  • data room

We not only support you in the development of your strategy, but also actively support you in the future.

proceed